...
首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells.
【24h】

Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells.

机译:晚期糖基化终产物对培养的人系膜细胞胞质Ca2 +信号转导的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Advanced glycation end product (AGE) accumulation in a high glucose (HG) environment is thought to mediate some of the vascular complications of diabetes. Transmembrane signaling of contractile cells is generally inhibited by HG, with implications for systemic and target organ hemodynamics. In the kidney, glomerular mesangial cells grown in HG media are hyporesponsive to the effects of vasoconstrictor agents, possibly explaining the hyperfiltration and increased capillary pressure that eventually lead to diabetic glomerulopathy. To verify whether AGE binding to specific mesangial receptors could mediate these effects of HG, cultured human mesangial cells (HMC) were exposed to in vitro glycated bovine serum albumin (BSA) for 60 min at 37 degrees C before measurement of cytosolic Ca2+ ([Ca2+]i) by microfluorometric techniques in monolayers or single cells. AGE-BSA (2 mg/ml) reduced Ca2+ release from intracellular stores by 1 microM angiotensin II from peak [Ca2+]i levels of 843+/-117 to 390+/-50 nM in monolayers and from 689+/-68 to 291+/-36 nM in individual cells (P < 0.05). Nonglycated BSA and BSA exposed to 250 mM glucose-6-phosphate for 30 d in the presence of 250 mM aminoguanidine (AMGD), an inhibitor of nonenzymatic glycation, had no effect on the angiotensin II-induced [Ca2+]i spike (peak 766+/-104 and 647+/-87 nM, monolayers/ single cells, respectively, P = NS). AGE also inhibited store-operated Ca2+ influx through plasma membrane channels, assessed by addition of 1 to 10 mM extracellular Ca2+ to cells previously held in Ca2(+)-free media (control 339+/- 46/593 +/- 51, +AGE-BSA 236 +/- 25/390 +/- 56, +AMGD 483+/-55/ 374+/-64 nM [Ca2+]i, monolayers/single cells at 10 mM Ca2+, respectively; +AGE-BSA, P < 0.05 versus control). Contrary to HG, AGE-BSA did not translocate protein kinase C isoforms alpha, zeta, and delta to the plasma membrane. Culture of HMC in HG supplemented with 1 mM AMGD prevented downregulation of [Ca2+]i signaling. These data suggest that glycated macromolecules or matrix components may inhibit transmembrane Ca2+ signaling of glomerular cells through binding to a specific AGE receptor, thus mediating some of the known functional effects of HG on the kidney.
机译:高糖(HG)环境中晚期糖基化终产物(AGE)的积累被认为可介导糖尿病的某些血管并发症。收缩细胞的跨膜信号传导通常受HG抑制,对全身和靶器官的血流动力学有影响。在肾脏中,在HG培养基中生长的肾小球系膜细胞对血管收缩药的反应低下,这可能解释了最终导致糖尿病性肾小球病的超滤和毛细血管压力升高。为了验证AGE与特定系膜受体的结合是否可以介导HG的这些作用,在测量胞质Ca2 +([Ca2 +]后,将培养的人系膜细胞(HMC)在37摄氏度下暴露于体外糖化牛血清白蛋白(BSA)60分钟。 ] i)通过微荧光技术在单层或单细胞中进行。 AGE-BSA(2 mg / ml)将单细胞层的[Ca2 +] i峰值水平从843 +/- 117降低至390 +/- 50 nM,从689 +/- 68降低至1 microM血管紧张素II,从而降低了细胞内存储中的Ca2 +释放。单个细胞中为291 +/- 36 nM(P <0.05)。非糖化BSA和BSA在250 mM氨基胍(AMGD)(一种非酶糖基化抑制剂)的存在下暴露于250 mM葡萄糖-6-磷酸30天,对血管紧张素II诱导的[Ca2 +] i峰值没有影响(峰值766) +/- 104和647 +/- 87 nM,分别为单层/单细胞,P = NS)。 AGE还抑制了通过质膜通道的存储操纵性Ca2 +流入,通过向先前保存在不含Ca2(+)的培养基中的细胞中添加1至10 mM胞外Ca2 +来评估(对照339 +/- 46/593 +/- 51,+ AGE-BSA 236 +/- 25/390 +/- 56,+ AMGD 483 +/- 55/374 +/- 64 nM [Ca2 +] i,分别为10 mM Ca2 +的单层/单细胞; + AGE-BSA,与对照相比,P <0.05)。与HG相反,AGE-BSA不会将蛋白激酶C的同种型α,ζ和δ转移到质膜上。 HG中添加1 mM AMGD的HMC培养可防止[Ca2 +] i信号的下调。这些数据表明糖基化的大分子或基质成分可能通过与特定的AGE受体结合而抑制肾小球细胞的跨膜Ca2 +信号传导,从而介导了HG对肾脏的某些已知功能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号